Younger patients with relapsed MDS may benefit from DLI post-stem cell transplant, improving overall survival rates. DLI is associated with graft-versus-host disease, but its impact on prognosis is ...
Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have ...
Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have ...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) represents one of the earliest and most successful forms of cellular immunotherapy. However, ...
Biology of Disease Relapse in Myeloid Disease: Implication for Strategies to Prevent and Treat Disease Relapse After Stem-Cell Transplantation The article by Schmid et al entitled “Defining the Role ...
The author(s) indicated no potential conflicts of interest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results